S. 476 · 118th Congress (2023–2025)
Maintaining Investments in New Innovation Act
This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)
Show official title
A bill to amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 476’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Robert Menendez (D-NJ)
- Cosponsors
3 cosponsors
1 original · 2 later
- Sen. Marsha Blackburn (R-TN)· Original · Feb 16, 2023
- Sen. Ted Budd (R-NC)· Later · Nov 14, 2023
- Sen. Steve Daines (R-MT)· Later · Jun 17, 2024
- Policy area
- Health
- Subjects
- Genetics
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Maintaining Investments in New Innovation Act
Display title, Short title · Introduced in Senate
A bill to amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Official title · Introduced in Senate